Hereditary Thrombophilia and Venous Thromboembolism: Critical Evaluation of the Clinical Implications of Screening

European Journal of Vascular and Endovascular Surgery

Volumn 34, Issue 4, 2007, Pages 483-488

  Mazzolai, L ^a   Duchosal, M A ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

FV Leiden; Screening; Thrombophilia; VTE recurrence

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN III; BLOOD CLOTTING FACTOR 5 LEIDEN; ORAL CONTRACEPTIVE AGENT; PROTEIN C; PROTEIN S; PROTHROMBIN;

ARTICLE; CLINICAL PRACTICE; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; GENE MUTATION; GENETIC SCREENING; HEALTH BEHAVIOR; HEREDITY; HUMAN; LABORATORY TEST; LONG TERM CARE; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; RELATIVE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; THROMBOPHILIA; TREATMENT DURATION; TREATMENT INDICATION; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; RECURRENCE; RISK ASSESSMENT; THROMBOEMBOLISM; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 34548611217     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2007.04.023     Document Type: Article

References (16)

1. Gray H.W. The natural history of venous thromboembolism: impact on ventilation/perfusion scan reporting. Semin Nucl Med 32 3 (2002 July) 159-172
2. Anderson F.A., Wheeler H.B., Goldberg R.J., Hosmer D.W., Patwardhan N.A., Jovanovic B., et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 151 5 (1991 May) 933-938
3. Silverstein M.D., Heit J.A., Mohr D.N., Petterson T.M., O'Fallon W.M., and Melton III L.J. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 158 6 (1998 March 23) 585-593
4. van der Meer F.J., Koster T., Vandenbroucke J.P., Briet E., and Rosendaal F.R. The Leiden Thrombophilia Study (LETS). Thromb Haemost 78 1 (1997 August) 631-635
5. Cushman M., Tsai A.W., White R.H., Heckbert S.R., Rosamond W.D., Enright P., et al. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med 117 1 (2004 July 1) 19-25
6. Cushman M. Inherited risk factors for venous thrombosis. Hematology Am Soc Hematol Educ Program (2005) 452-457
7. Christiansen S.C., Cannegieter S.C., Koster T., Vandenbroucke J.P., and Rosendaal F.R. Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA 293 19 (2005 May 18) 2352-2361
8. Baglin T., Luddington R., Brown K., and Baglin C. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet 362 9383 (2003 August 16) 523-526
9. The PROCARE group. Is recurrent venous thromboembolism more frequent in homozygous patients for the factor V Leiden mutation than in heterozygous patients?. Blood Coagul Fibrinolysis 14 6 (2003 September) 523-529
10. Vossen C.Y., Walker I.D., Svensson P., Souto J.C., Scharrer I., Preston F.E., et al. Recurrence rate after a first venous thrombosis in patients with familial thrombophilia. Arterioscler Thromb Vasc Biol 25 9 (2005 September) 1992-1997
11. Geerts W.H., Pineo G.F., Heit J.A., Bergqvist D., Lassen M.R., Colwell C.W., et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 Suppl. 3 (2004 September) 338S-400S
12. Vossen CY., Conard J., Fontcuberta J., Makris M., van der Meer F.J., Pabinger I., et al. Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT). J Thromb Haemost 3 3 (2005 March) 459-464
13. van der Meer F.J., Rosendaal F.R., Vandenbroucke J.P., and Briet E. Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. Arch Intern Med 153 13 (1993 July 12) 1557-1562
14. Palareti G., Leali N., Coccheri S., Poggi M., Manotti C., D'Angelo A., et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet 348 9025 (1996 August 17) 423-428
15. Machin S.J. Pros and cons of thrombophilia testing: cons. J Thromb Haemost 1 3 (2003 March) 412-413
16. Somma J., Sussman II, and Rand J.H. An evaluation of thrombophilia screening in an urban tertiary care medical center: a "real world" experience. Am J Clin Pathol 126 1 (2006 July) 120-127